PETER GRANGAARD: Open Payments
NPI 1356886733 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 53 payments from 10 companies in 2025. Trend: 2023 $267 · 2024 $492 · 2025 $1,244
Food & beverage: $1,144Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $361 |
| Janssen Biotech, Inc. | 9 | $310 |
| Novartis Pharmaceuticals Corporation | 14 | $303 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| Amgen Inc. | 4 | $78 |
| GENZYME CORPORATION | 1 | $28 |
| Radius Health, Inc. | 1 | $25 |
| Alvogen Inc | 1 | $18 |
| SOBI, INC | 1 | $15 |
| Organon LLC | 1 | $6 |
Products named: TREMFYA, COSENTYX, RINVOQ, SKYRIZI, BENLYSTA, EVENITY, KEVZARA, Tymlos.
Industry payments across FL — which companies pay providers there.
